Identification of DDB2 Protein as a Transcriptional Regulator of Constitutive SOD2 Gene Expression in Human Breast Cancer Cells

• Published in: The Journal of biological chemistry 2009-05, Vol.284 (21), p.14165-14176
• Main Authors: Minig, Vanessa, Kattan, Zilal, van Beeumen, Josef, Brunner, Emilie, Becuwe, Philippe
• Format: Article
• Language: English
• Subjects: Base Sequence; Breast Neoplasms - enzymology; Breast Neoplasms - genetics; Breast Neoplasms - pathology; Cell Line, Tumor; Cell Proliferation; DNA, Neoplasm - metabolism; DNA-Binding Proteins - isolation & purification; DNA-Binding Proteins - metabolism; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Histones - metabolism; Humans; Molecular Sequence Data; Promoter Regions, Genetic - genetics; Protein Binding; Protein Processing, Post-Translational; Superoxide Dismutase - genetics; Superoxide Dismutase - metabolism; Transcription Factors - metabolism; Transcription, Chromatin, and Epigenetics; Transcription, Genetic
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1074/jbc.M808208200

Manganese superoxide dismutase plays a role in breast tumor cell growth, which depends on its constitutive expression. However, the mechanisms responsible for the regulation of constitutive SOD2 gene expression at different malignant phenotype in breast cancers remain to be determined. The present study reports the identification and characterization of a DNA sequence located in the proximal promoter of the SOD2 gene, which forms a complex with a nuclear protein from breast tumor MCF-7 cells. Purification of this complex showed that it contained DDB2 (damaged DNA binding 2), a well known protein involved in nucleotide excision DNA repair and cell cycle regulation. Functional analysis of the proximal promoter of the SOD2 gene or modulation of DDB2 expression allowed us to demonstrate that DDB2 regulates negatively the constitutive expression of the SOD2 gene in breast cancer cells. We demonstrate that the binding of DDB2 was associated with the loss of acetylated H3 histones and the decrease in the binding of Sp1 but not AP-2α transcription factors to the SOD2 proximal promoter. In addition, we show that DDB2 exerts, at least in part, a control of breast cancer cell growth through its negative regulation of constitutive expression of the SOD2 gene. For the first time, these data give supporting evidence that DDB2 is a new transcriptional regulator, and they provide insight into the molecular function of breast cancer cell growth, which will have an important clinical interest.